Inventor · disambiguated record
Russell Gotschall
Also filed as: GOTSCHALL RUSSELL
15 granted patents·12 pending applications·81 citations·filing 2015–2025
93Inventor score
Top patents by PatentIndex Score
27 records- 0197US11591583B2Highly potent acid alpha-glucosidase with enhanced carbohydratesAMICUS THERAPEUTICS INC·Filed 2022·Granted Feb 28, 2023·3 cites·16 claims
- 0296US11753632B2Highly potent acid alpha-glucosidase with enhanced carbohydratesAMICUS THERAPEUTICS INC·Filed 2021·Granted Sep 12, 2023·3 cites·19 claims
- 0396US11278601B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 0495US10857212B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·7 cites·31 claims
- 0594US10961522B2Highly potent acid alpha-glucosidase with enhanced carbohydratesAMICUS THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·9 cites·12 claims
- 0694US10208299B2Highly potent acid alpha-glucosidase with enhanced carbohydratesAMICUS THERAPEUTICS INC·Filed 2015·Granted Feb 19, 2019·12 cites·18 claims
- 0793US11491243B2Gene therapy constructs and methods of useAMICUS THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·4 cites·18 claims
- 0892US10227577B2Method for selection of high M6P recombinant proteinsAMICUS THERAPEUTICS INC·Filed 2017·Granted Mar 12, 2019·11 cites·10 claims
- 0991US10874750B2Gene therapy constructs and methods of useAMICUS THERAPEUTICS INC·Filed 2019·Granted Dec 29, 2020·7 cites·19 claims
- 1091US10512676B2Formulations comprising recombinant acid alpha-glucosidaseAMICUS THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·14 cites·23 claims
- 1188US11491211B2Formulations comprising recombinant acid alpha-glucosidaseAMICUS THERAPEUTICS INC·Filed 2019·Granted Nov 8, 2022·3 cites·23 claims
- 1284US11441138B2Method for selection of high M6P recombinant proteinsAMICUS THERAPEUTICS INC·Filed 2019·Granted Sep 13, 2022·1 cites·9 claims
- 1384US2023203465A1Highly Potent Acid Alpha-Glucosidase With Enhanced CarbohydratesAMICUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1481US11357834B2Recombinant α-galactosidase A for treatment of Fabry diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·1 cites·24 claims
- 1580US12414985B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2022·Granted Sep 16, 2025·0 cites·33 claims
- 1677US12246062B2Recombinant human acid alpha-glucosidaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Mar 11, 2025·1 cites·19 claims
- 1776US2025057925A1Recombinant Human Acid Alpha-GlucosidaseAMICUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1875US2023079225A1Method For Selection Of High M6P Recombinant ProteinsAMICUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1974US2025381254A1Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseAMICUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2072US2024066104A1Formulations comprising recombinant acid alpha-glucosidaseAMICUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2172US2023233711A1Gene therapy constructs and methods of useAMICUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2267US2023158123A1Recombinant Alpha-Galactosidase A For Treatment Of Fabry DiseaseAMICUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2366US2017189497A1Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseAMICUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2457US2022193261A1Compositions useful for treatment of pompe diseaseUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2557US2024197839A1Recombinant Human Acid Alpha-Glucosidase and Uses ThereofAMICUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2655US2023173108A1Compositions useful for treatment of pompe diseaseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2750US2024091321A1Variant igf2 constructsAMICUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Russell Gotschall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →